MAEVE
Identification of Maeve
| No description |
Google image searchProduct monograph
Active ingredient
norethindrone, 0.35 MG
DIN: 02458683
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
Date: 16-DEC-2022
ATC:
- G03 — SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (ATC, ATC/DDD, )
- G03A — HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE (ATC, ATC/DDD)
- G03AC — Progestogens (ATC, ATC/DDD)
- G03AC01 — NORETHISTERONE (ATC/DDD)
Reference brand drug: Micronor
Pharmaceutical standard: USP
